Archive for the ‘La Jolla Pharmaceuticals Co’ Category

La Jolla Pharmaceutical

February 23rd, 2015 | Posted in 2015, La Jolla Pharmaceuticals Co

La Jolla Pharmaceutical Co. announced an agreement with the FDA on a special protocol that will allow the company to proceed with its Phase 3 clinical trial for is proposed treatment for a deadly blood pressure ailment known as catecholamine-resistant hypotension.